Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference
Portfolio Pulse from Vandana Singh
At the RBC Global Healthcare Conference, Chris McCarthy highlighted biotech companies with upcoming data readouts that could lead to significant stock movements. Key companies mentioned include Agios Pharmaceuticals (AGIO), Caribou Biosciences (CRBU), and Corbus Pharmaceuticals (CRBP).
May 16, 2024 | 6:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Agios Pharmaceuticals has two key milestones in 2024, including topline data from the Phase 3 ENERGIZE-T study and filing for FDA approval of mitapivat in thalassemia.
Upcoming data readouts and FDA filing are significant events that could lead to outsized stock moves for Agios Pharmaceuticals.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Corbus Pharmaceuticals plans a clinical data update at ASCO 2024 for the China dose escalation study.
A clinical data update at a major conference could lead to increased investor interest and potential stock movement for Corbus Pharmaceuticals.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
Caribou Biosciences plans to present data at the 2024 ASCO Annual Meeting and has multiple trials with data readouts expected by year-end 2024.
Presenting data at a major conference and multiple trial readouts are key events that could reinvigorate investor interest in Caribou Biosciences.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85